Plasma proteomics outpredicts HbA1c for 10-year cardiometabolic disease risk in Nature Metabolism study

EricTopol · x · 2026-11-16

An open-access Nature Metabolism study identifies plasma proteomic insulin-resistance signatures that predict 10-year incident disease risk better than current metrics like HbA1c, TG/HDL ratio, and LDL. Across 20+ conditions — type 2 diabetes, fatty liver, end-stage renal disease, heart failure, hypertension, dementias, and multiple cancers — the proteomic 'predicted M value' showed higher C-index in the test set, with large cohorts per disease (e.g., 898 diabetes cases, 3,551 hypertension cases).

Original post →

More from Research

Research channel →